With 64% Ownership in ATyr Pharma, Inc. (NASDAQ:ATYR), Institutional Investors Have a Lot Riding on the Business
Express News | Point72 Asset Management, L.p. Reports 6.2% Passive Stake in aTyr Pharma as of Oct 14 - SEC Filing
ATyr Pharma Management to Meet Virtually With Piper Sandler
ATyr Pharma to Present at the LD Micro Main Event XVII in October
ATyr Pharma's Lead Therapeutic Candidate Efzofitimod For Pulmonary Sarcoidosis To Be Featured In Best Of CHEST Journals At CHEST 2024 Annual Meeting October 6 – 9, 2024
Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and ATyr Pharma (ATYR)
